Covidien touts FDA clearance for its novel camera-equipped Kangaroo feeding tube designed to provide visualization for an otherwise blind procedure.
Medtech titan Covidien (NYSE:COV) received FDA clearance for its visual Kangaroo feeding tube, equipped with an endoscopic camera that allows physicians to see into the procedure in a new way.
Covidien reportedly agreed to a $100 million buyout of New Wave Surgical and its D-Help device, designed to keep endoscope lenses clear during surgeries.
Covidien (NYSE:COV) reportedly paid $100 million to acquire New Wave Surgical and its medical device for keeping endoscope lenses clear during surgeries.
Covidien recalls some of its Pipeline and Alligator devices, designed to treat brain aneurysms, after internal testing turned up a potentially lethal problem with the devices' guidewire.
Covidien (NYSE:COV) said it's recalling some of its Pipeline and Alligator brain embolism devices after internal testing revealed a potentially lethal problem with the guidewires used to deliver them.
Here's a look at some of the top personnel stories for medical device companies this week.
Malta regulators announced this week that healthcare titan Baxter plans to add 30 additional jobs in the country.
Here's a look at some of the top regulatory stories for medical device companies this week.
Class I recalls: 10
Class II recalls: 183
Stephen Fanning, the former CEO of Solta Medical, is Z-Medica's new chief.
Z-Medica said it named Stephen Fanning, the former CEO of Solta Medical, to be its new chief executive.
Wallingford, Conn.-based Z-Medica is developing blood clotting technologies it calls QuikClot.
Here's a look at some of the top Wall Street stories for medical device companies this week.
, American College of Cardiology
, Arterial Remodeling Technologies
, Baxter International
, Edwards Lifesciences
, K-C Health Care
, Kimberly-Clark Worldwide Inc.
, Smith & Nephew
, Terumo Corp.
, Urologix Inc.
, Abbott Laboratories